Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 20/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 16/20 | 0.47 |
| ▸ | GSK3B | P49841 | 5/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.44 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3560570 | 0.84 | CDK2 (0.45) | CDK2CCNE1GSK3BCCNA2CCNA1 | |
| SCHEMBL3559853 | 0.81 | CDK2 (0.55) | CDK2CCNE1CCNA2CCNA1 | |
| SCHEMBL3133266 | 0.80 | CCNE1 (0.60) | CDK2CCNE1GSK3B | |
| SCHEMBL3133459 | 0.79 | CDK2 (0.49) | CDK2CCNE1GSK3B | |
| SCHEMBL25941301 | 0.79 | CDK2 (0.67) | CDK2CCNE1GSK3B | |
| SCHEMBL25938137 | 0.79 | CDK2 (0.67) | CDK2CCNE1GSK3B | |
| SCHEMBL3130801 | 0.78 | CDK2 (0.49) | CDK2CCNE1GSK3B | |
| SCHEMBL3130806 | 0.78 | CDK2 (0.49) | CDK2CCNE1GSK3B | |
| SCHEMBL3133072 | 0.76 | CCNE1 (0.48) | CDK2CCNE1GSK3B | |
| SCHEMBL5867732 | 0.73 | CCNA2 (0.62) | CDK2CCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671072-B2 | Aminopyrazole derivatives as GSK-3 inhibitors | PFIZER INC. (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | BENBOW JOHN W | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | GSK3B, GSK3A, GSKIP | CDK2 58/4885CCNE1 420/4885GSK3B 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.